ERO:PA:PA-SPDR MSCI Europe UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 339.206

Change

+0.14 (+0.04)%

Market Cap

USD 0.32B

Volume

66.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.48 (-1.06%)

USD 56.03B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-0.30 (-0.06%)

USD 13.60B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-0.30 (-0.08%)

USD 11.29B
WRD:PA HSBC MSCI World UCITS ETF

N/A

USD 11.04B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.20 (+0.46%)

USD 10.45B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

N/A

USD 7.99B
WLD:PA Lyxor UCITS MSCI World D-EUR

+0.10 (+0.03%)

USD 7.49B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

+0.10 (+1.53%)

USD 7.42B
HHH:PA HSBC S&P 500 UCITS ETF

-0.04 (-0.07%)

USD 7.22B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

+0.17 (+0.21%)

USD 5.38B

ETFs Containing ERO:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.01% 84% B 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.01% 83% B 70% C-
Trailing 12 Months  
Capital Gain 8.94% 64% D 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.94% 61% D- 66% D+
Trailing 5 Years  
Capital Gain 72.64% 68% D+ 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 72.64% 64% D 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 11.05% 69% C- 72% C
Dividend Return 11.05% 66% D+ 68% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.85% 60% D- 78% C+
Risk Adjusted Return 101.84% 84% B 89% A-
Market Capitalization 0.32B 56% F 63% D

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike